Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice
Highlights
► This study is the first report about the protection role of CYP2J2 in diabetic nephropathy in vivo. ► Endothelial overexpression of CYP2J2 attenuates activation of the TGF-β/Smad signaling pathway in diabetic kidney mice. ► EETs attenuate TGF-β1-induced tubular epithelial–mesenchymal transdifferentiation on HK-2 cells. ► EETs attenuate the effects of TGF-β1 through a mechanism that involves activation of EGFR and PPARγ.
Introduction
Approximately 20–30% of all diabetic patients develop evidence of diabetic nephropathy (DN), which represents a continuum from microalbuminuria, to overt nephropathy or macroalbuminuria, and finally end stage renal disease (ESRD) [1]. Indeed, DN is the main cause of ESRD requiring dialysis in developed countries [2]. DN is initiated by hyperglycemia and is characterized by mesangial expansion and thickening of the tubular and glomerular basement membranes due to excessive matrix accumulation, associated with progressive renal deterioration [3]. However, a recent study has indicated that tubular injury and progressive interstitial fibrosis are more closely related to DN prognosis [4]. TGF-β and its downstream signal transduction pathways play a major role in DN and have therefore been thoroughly studied [5]. Among the features of the diabetic milieu, hyperglycemia, increased non-enzymatic glycation of proteins, de novo synthesis of diacylglycerol and subsequent activation of protein kinase C, increased intracellular glucosamine production, and enhanced renal production of vasoactive agents (angiotensin II, endothelins, thromboxane) have all been shown to increase the expression of TGF-β in cultured renal cells and in animal models of DN [6]. With the emerging evidence that TGF-β is involved in the pathogenesis and progression of DN, potential treatments with specific factors that interrupt the activity of TGF-β have become promising and attractive.
Epoxyeicosatrienoic acids (EETs), cytochrome P450 (CYP) epoxygenase metabolites of arachidonic acids (AAs), have diverse biological effects within the cardiovascular system and have been identified as endothelium-derived hyperpolarizing factors, which activate calcium-sensitive potassium channels resulting in hyperpolarization of the resting membrane potential and the relaxation of vascular smooth muscle cells [7]. CYP epoxygenases are highly expressed in cardiomyocytes and vascular endothelial cells [8]. CYP epoxygenase overexpression, and the corresponding increase in EET levels, promotes an angiogenic phenotype, including endothelial cell proliferation, migration, and capillary tubule formation, as well as significantly protects endothelial cells from TNF-α induced apoptosis [9], [10]. EETs upregulate eNOS in bovine aortic endothelial cells via activation of MAPK, protein kinase C, PI3-kinase/AKT, and MAPK signaling pathways [11], [12]. 14,15-EET mediated mitogenic signaling pathway in a kidney epithelial cell line, which involved EET-dependent activation of metalloproteinases and release of the potent mitogenic EGFR ligand, HB-EGF [13]. EETs participate as second messengers in the angiogenic response initiated by VEGF and that preventing the increase in CYP expression curtails the angiogenic response to VEGF [14]. Blocking PPARγ by GW9662 abolished the EET-mediated anti-inflammatory effect, which indicates that PPARγ is an effector of EETs [15]. In the pancreas, CYP epoxygenase expression and EET production suggest that EETs also may be involved in pancreatic hormone secretion [16]. Indeed, 5,6-EET directly stimulates insulin release from isolated rat pancreatic islets in vitro [17].
CYP, family 2, subfamily J, polypeptide 5 epoxygenase (CYP2J5) produces EETs and is highly expressed in the proximal tubule and collecting duct of mice [18]. The inhibition of soluble epoxide hydrolase 2 (EPHX2), the primary EET metabolizing enzyme, results in increased EET levels, which has been shown to attenuate the progression of renal damage associated with hypertension and type II diabetes [19]. The human ortholog of mouse CYP2J5 is CYP2J2 [20]. Our previous CYP2J3 gene therapy studies have demonstrated alleviation of insulin resistance and diabetic symptoms in db/db mice and fructose-induced insulin resistant rats [21]. We hypothesize that endothelial CYP2J2 overexpression and the resultant increase in EET production will attenuate DN in streptozotocin (STZ)-treated mice. Furthermore, we postulate that TGF-β1-induced changes in cultured kidney cells will be attenuated by the administration of exogenous EETs.
Section snippets
Materials
Horseradish peroxidase-conjugated goat anti-rabbit and anti-mouse IgG were obtained from Jackson ImmunoResearch Laboratories (Soham, UK). Enhanced chemiluminescence reagent was purchased from Pierce Chemical (Rockford, IL), pre-stained molecular weight standards were from Bio-Rad (Hercules, CA), and polyvinylidene difluoride membranes were from Schleicher and Schuell (Dassel, Germany). Antibodies against p-samd3, smad3, smad4, smad7 and α-SMA were purchased from Sigma–Aldrich (St. Louis, MO).
Metabolic characteristics and renal function in streptozotocin-induced diabetic mice
Table 1 lists the biochemical and physiological parameters of WT and Tie2-CYP2J2 transgenic mice in both control and STZ-treated groups. Administration of STZ to mice significantly increased the ratio of kidney weight to body weight, blood glucose, HbA1c (A1C), blood urea nitrogen, plasma creatinine, urinary microalbumin levels and decreased urinary osmolarity compared with control mice group(P < 0.05), indicating the characteristics of diabetic renal dysfunction and establishment of the early
Discussion
In this study, we injected one-low dose STZ (50 mg/kg body weight) daily by I.P. for 5 consecutive days to induce a diabetic state characterized by hyperglycemia and hypoinsulinemia in mice. We examined the effects of endothelial CYP2J2 overexpression on diabetic nephropathy, including renal function and morphology. We found that endothelial CYP2J2 overexpression attenuated the detrimental effects associated with DN. Specifically, CYP2J2 overexpression decreased hyperglycemia, improved renal
Acknowledgments
This work was supported by funds from the National Education Ministration project, Nature Science Foundation Committee projects (Nos. 30930039, 30700377) and Wuhan City grant.
References (55)
- et al.
Diabetic nephropathy: important pathophysiologic mechanisms
Diabetes Res Clin Pract
(2008) - et al.
TGF-beta and fibrosis in different organs—molecular pathway imprints
Biochim Biophys Acta
(2009) - et al.
Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets
Biochem Biophys Res Commun
(1983) - et al.
Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney
J Biol Chem
(1999) - et al.
Utility of endogenous creatinine clearance as a measure of renal function in mice
Kidney Int
(2004) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
Anal Biochem
(1976)- et al.
Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats
Kidney Int
(1984) - et al.
Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation
Am J Pathol
(2002) - et al.
Transforming growth factor-beta regulates tubular epithelial–myofibroblast transdifferentiation in vitro
Kidney Int
(1999) - et al.
Advanced glycation end products induce tubular epithelial–myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway
Am J Pathol
(2004)
Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats
J Am Soc Nephrol
Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-beta1 dependent and TGF-beta1 independent pathways
Nephrol Dial Transplant
Effect of activin A on tubulointerstitial fibrosis in diabetic nephropathy
Nephrology (Carlton, Vic.)
The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy
Ren Fail
Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning
J Cardiovasc Pharmacol
P-450 metabolites of arachidonic acid in the control of cardiovascular function
Physiol Rev
Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways
J Pharmacol Exp Ther
Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways
Am J Physiol Heart Circ Physiol
Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways
J Pharmacol Exp Ther
Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors
Cancer Res
Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells
Proc Natl Acad Sci USA
Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis
Am J Physiol Cell Physiol
The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase
Proc Natl Acad Sci USA
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats
Clin Sci (Lond)
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants
Pharmacogenetics
Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice
Diabetes
Cited by (38)
Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome
2020, Prostaglandins and Other Lipid MediatorsCitation Excerpt :Several studies have suggested a role of PUFA-epoxides in preventing the development of MetS [55], though with few exceptions [56], the majority of the studies did not assess the concentrations of PUFA epoxides and diols in the models studied. CYP: On the whole the epoxides generated by CYP enzymes are reported to be protective and overexpression of the human CYP2J2 in mice made diabetic with streptozotocin was reported to attenuate diabetic nephropathy [57], and cardiomyopathy (58). The mechanisms implicated were many and varied and included the ability to decrease oxidative and ER stress, to reduce hyperglycaemia, and/or to improve mitochondrial function [58,59], together with anti-inflammatory effects and insulin sensitization [60].
Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell
2019, Life SciencesCitation Excerpt :Accumulating evidence has demonstrated that EETs exhibit a protective effect against diabetes and DN [13]. Overexpression of CYP2J2, resulting in an increase of EETs, prevents renal tubular epithelial-mesenchymal transition and attenuates renal damage in STZ-induced diabetic mice [14]. Furthermore, genetic disruption of soluble epoxide hydrolase, the primary enzyme hydrolyzing EETs into biologically less active dihydroxyeicosatrienoic acids, protects renal tubular epithelium against TNF-α-induced apoptosis [15].
Expression of CYP4V2 in human THP1 macrophages and its transcriptional regulation by peroxisome proliferator-activated receptor gamma
2017, Toxicology and Applied PharmacologyCitation Excerpt :Furthermore, PPARγ has been found to enhance macrophage uptake of oxidized LDL via transcriptional induction of CD36, a second-class scavenger receptor in macrophages (Goldwasser et al., 2010; Li and Glass, 2004; Nagy et al., 1998). It has been reported that the arachidonic acid metabolites EET, DHET, and 20-HETE can activate PPARγ (Chen et al., 2011; Hardwick et al., 2013), suggesting that the increased levels of fatty acids may activate PPARγ in THP1 macrophages to remove the burden of fatty acid accumulation in the macrophages. It would be important to determine the expression level and role of CYP4V2 in blood monocytes, differentiated macrophages, and foam cells from human subjects in future studies.
Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice
2015, Prostaglandins and Other Lipid MediatorsSoluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway
2015, Biochemical and Biophysical Research Communications